You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Rapid Response Vaccines for Botulinum Neurotoxins
SBC: Iterative Therapeutics Inc. Topic: NIAIDDESCRIPTION (provided by applicant): Botulinum neurotoxins (BoNTs) are the most potent protein toxins known. Given their potent toxicity and their potential use in bio-warfare scenarios, BoNTs are included among the Category A select agents. The currentlyavailable pentavalent toxoid vaccine requires multiple boosters before being effective, and protects unequally against the different BoNT serotyp ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Rapid screening tool for antibiotic resistant pathogens
SBC: Resonant Sensors Incorporated Topic: NIAIDDESCRIPTION (provided by applicant): The innovation presented in this proposal is a new class of label-free biochemical sensors with applicability in point of care (POC) medical diagnostics. The goal of the project to develop commercial biochip systems with compelling performance metrics targeted for rapid screening of an array of antibiotic resistant microbials in a clinical setting. The biochips ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
HEPylated G-CSF: Drug with Safer, Enhanced Delivery for Neutropenia Treatment
SBC: CAISSON BIOTECH, LLC Topic: NCIDESCRIPTION (provided by applicant): Poly[ethylene glycol] (PEG) polymers are widely used by pharma to enhance the physical, chemical, and/or biological nature of promising drug candidates. The process of adding PEG polymers to drug cargo is termed PEGylation and has resulted in several Billion/year drugs. PEGylation protects the cargo when in the body and prolongs therapeutic action. For patient ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Multifunctional Peptides for (MRI) Imaging
SBC: CDG THERAPEUTICS, INC. Topic: NCIDESCRIPTION (provided by applicant): Our overall goal is to expand the role of CPPs in molecular imaging at the patient level using large animal models of human tumors and a peptide agent that inherently provides 1) preferential access to a wide variety ofhuman solid (and hematologic) tumor cells, 2) an increased intracellular concentration (2-12 fold) over histologically matched normal cells, and ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Optimal Prevention and Control of Periodontal Disease: The Periodontal Pocket Irr
SBC: C. PAXTON DESIGNS INC. Topic: NIDCRDESCRIPTION (provided by applicant): Periodontal disease is a chronic bacterial infection that affects the gums and bone that surrounds supported teeth. According to the NIH fact sheet an estimated 80 percent of American adults have some form of periodontal disease. Gingivitis, a milder form of gum disease, is caused by plaque bio-film, which surrounds the teeth at the base of the gum line, causin ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Novel Small Molecules for Treating Kidney Disease
SBC: CRO LABORATORIES, INC. Topic: NIDDKDESCRIPTION: Chronic kidney disease (CKD) is a significant and rapidly growing global health crisis. CKD is associated with cardiovascular disease, hypertension, diabetes, obesity, and aging. It is characterized by gradual loss of renal function with increasing proteinuria (albuminuria), interstitial fibrosis, and glomerulosclerosis. Small increases in urinary protein are associated with markedly ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
New drug Vida-5 for treating chronic kidney disease progression
SBC: Vidasym, Inc Topic: NIDDKDESCRIPTION (provided by applicant): Twenty-six million people in America have chronic kidney disease (CKD). Anemia, cardiovascular diseases, secondary hyperparathyroidism, renal osteodystrophy and other complications are common in CKD. Current treatmentsincluding ACE inhibitors for CKD patients mainly focus on managing symptoms and disease complications. Despite the various treatments available, ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
E-Learning Assisted HAZWOPER Training for Coroners and Medical Examiners
SBC: D&E TECHNICAL, INC Topic: NIEHSDESCRIPTION (provided by applicant): Human death investigations must by law be properly implemented even when the decedent is involved in or near to the scene of a hazardous materials emergency. This project intends to develop worker health and safety training for those staff of coroners and medical examiners who investigate deaths in hazardous materials environments. This innovative training will ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Portable Instrument for Chemifluorescent Detection of Lead in Dust
SBC: Strategic Government Business Consulting Group, Ltd Topic: NIEHSDESCRIPTION (provided by applicant): Lead poisoning has been identified as the number one environmental health problem in the United States affecting children. The CDC estimates that 30 percent of in inner city children have high lead levels and that one million children have lead levels greater than 10 5g/dL of blood. Childhood exposure to low levels of lead have been shown to cause permanent neu ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Field Deployable Vapor Intrusion Monitor
SBC: LYNNTECH INC. Topic: NIEHSDESCRIPTION (provided by applicant): Vapor intrusion is the migration of volatile chemicals from the subsurface into overlying buildings, one of the major causes for a large population exposure to hazardous chemicals. These volatile chemicals are often theresult of buried waste and/or contaminated groundwater that can emit vapors that may migrate through subsurface soils and into indoor air spaces ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health